Faeth Therapeutics, Inc. (FTH) Diversifiers

Equity · Currency in USD · Last updated Jun 19, 2026

Faeth Therapeutics, Inc. (formerly Sensei Biotherapeutics, Inc.) is a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its lead program, PIKTOR, is an investigational all-oral multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer.

Looking to balance out your exposure to FTH? The ETFs below have the lowest correlation with FTH — they tend to move on their own, which can help reduce risk when FTH drops. The stock ideas table highlights individual companies that behave independently from FTH.

No Diversifiers Found for FTH

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements FTH

Add FTH to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with FTH